Efrain Reisin
USA
Efrain Reisin MD; FACP; FASN; FASH
Victor Chaltiel Professor of Medicine
Chief Section of Nephrology and Hypertension
LSUHSC, New Orleans, Louisiana
Dr. Efrain Reisin, Chief of the Section of Nephrology and Hypertension, joined the faculty of Louisiana State University School of Medicine in New Orleans in 1982. He maintains an active funded clinical and basic research program in Hypertension and Kidney Diseases, with a focus on functional and structural damages caused by the metabolic syndrome, obesity and diabetes.
He is the author of more than 160 scientific original publications, review articles and book chapters. Most notably, “The Anatomy of Success: The Top 100 Cited Scientific Reports Focused on Hypertension Research” published in 2014 includes one of Dr. Reisin’s publications in the area of Obesity Hypertension, an article which was also deemed a “Citation Classic” by Current Contents in 1998.
Dr. Reisin was the recipient of the Tinsley Harrison Award by the American Journal of the Medical Sciences (2010), and the recipient of the Kidney Hero Award given by the National Kidney Foundation of Louisiana (2015).
Additionally, Dr. Reisin has held numerous national leadership positions. He currently sits on the Editorial Board of the AJMS and the JASH, and he is a Section Editor of Current Hypertension Reports. He was the Chairman of the American Society of Nephrology Hypertension Advisory Group (2010- 2016); served on a panel Member of the Consensus Development Conference on Gastrointestinal Surgery for Severe Obesity by the NIH (1990); and a Member of The Hypertension in the Elderly Expert Consensus Document by the American College of Cardiology (2009-2010).
Dr. Reisin graduated from the National University of Cordoba, Argentina, completing his residency in Internal Medicine and fellowship in Nephrology at the Tel Hashomer Hospital, Tel Aviv University in Israel. He is a Fellow of the American College of Physicians, the American Society of Nephrology, the American Society of Hypertension and the Council of High Blood Pressure Research.
